Lansen Pharmaceutical Holdings Limited, owning several branches and sub-branches, is an investment and management platform established by Cathay International Holdings Limited (a listed company in UK) for the development of medicine and health industry in China. The Company was listed on the main board of HKEX on May 7th, 2010 (Stock Code: 00503.HK). Lansen has two modern production plants operated in Ningbo, China, covering an area of about 71,000m2 with a total construction area of about 36,600 m2 and is mainly engaged in research, development, production and sales of traditional Chinese medicine and chemical medicines relating to the fields of rheumatology, dermatology, medical cosmetology and plant extraction. Lansen is committed to becoming a comprehensive pharmaceutical enterprise group with good reputation and leading position in the industry.

　　Ningbo Liwah Pharmaceutical Co., Ltd., formerly known as Ningbo Traditional Chinese Medicine Factory, is a pharmaceutical manufacturing enterprise with a long history. The Company has been engaged in pharmaceutical industry for over 60 years and is recognized as a large pharmaceutical enterprise in Ningbo. As a national high-tech enterprise, the Company owns GMP standard plants, 8 production lines, the production approvals for over 70 kinds of products, and a group of experienced medical technicians. It is mainly responsible for the production of specialized medicine products and generic medicine products, the sales and promotion of generic medicine products and the R&D of new products under Lansen brand. Being the core product of the Company, total glucosides of paeony capsules has become the main medicine in the field of rheumatism and immunity in China, and is developing its international market at present. By adhering to the principles of "Be Earnest in Work and Steadfast in Life" and "Manufacturing Good Medicines for China", Liwah will make all efforts to provide the society with safe and reliable medicines.

　　Ningbo Lansen Pharmaceutical Co., Ltd. is a specialized pharmaceutical sales company affiliated to Lansen Pharmaceutical Holdings Limited. With its center in Ningbo, two branch centers in Shanghai and Beijing respectively, and a marketing network covering the whole nation, the Company is mainly engaged in the sales of products relating to rheumatology, dermatology and other fields. The main products of the Company are prescription and OTC medicine including total glucosides of paeony capsules, triclosan Cream, Dingpeng cream, Bazhen granule and compound glycyrrhiza oral solution, etc. Through the establishment of professional brand by professional products, as well as professional academic promotion by specialized personnel, the Company has implemented its brand strategy and developed itself into a brand enterprise.

　　By sticking to the concept of "Meeting the Market Needs by Continuous Innovation, Creating Value through Technical Service, and Realize Mutual Development with Customers", Lansen will strengthen its investment in R&D and enrich its product categories, thus improving the core competitiveness in the industry; meanwhile, it will integrate industrial resources through strategic transformation and strategic investment, so as to achieve sustainable development.

　　Lansen wishes to cooperate with you for the healthy life of all human beings!